The Muscle Mag
Laboratorios Columbia, a Mexican pharmaceutical company specializing in metabolic syndrome, announced in a press release their partnership with Slimbiotics. The collaboration will focus on product innovation, research and development, as well as quality and safety.
Regarding product innovation, the companies plan to work together on creating new nutraceutical products, with a specific focus on liver health based on findings from Slimbiotics’ initial clinical study.
A spokesperson for Slimbiotics mentioned that their clinical study showed significant improvements in liver steatosis among participants taking their probiotic compared to a placebo. Another clinical study is currently underway in Mexico to further support these benefits before any product is introduced.
Carlos Quintanilla, VP of business development at Lab Columbia, expressed excitement about the collaboration, stating: “Our shared vision of enhancing consumer health through innovative solutions makes this partnership a perfect match. We are eager to work together to benefit Mexican consumers, particularly in the area of liver health.”
History
Slimbiotics GmbH was established in 2019 by Austrian entrepreneurs Helmut Essl and Alexander Schütz. Their goal was to develop plant-derived biotics backed by clinical evidence to support metabolic wellness.
Prior to Slimbiotics, Essl founded HSO Health Care GmbH, a company offering the probiotic solution Astarte for women’s urogenital health. Astarte was later acquired by Chr. Hansen in 2020.
Slimbiotics has been focused on researching and commercializing their Kimere-derived probiotics. Kimere is an African fermented food that has shown promising strains beneficial for metabolic health.
These strains were initially discovered by a group of medical researchers, including a Kenyan PhD student, studying native African foods for their potential health benefits related to metabolism.
Essl commented on the partnership with Lab Columbia, stating: “This collaboration will allow us to leverage our strengths to accelerate the development of innovative health products, including those targeting liver health. Together, we aim to make a significant impact on the Mexican health market.”
